LINC00917

Across TCGA pan-cancer cohorts, LINC00917 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC00917’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC00917 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00917 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

COAD, THCA, and HNSC are the cancer types where LINC00917 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00917 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.017	.008	4	view →
THCA	All	All	+0.006	.031	3	view →
HNSC	All	All	+0.034	.029	1	view →
KIRP	Male	All	−0.006	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC00917–COAD

Open the COAD breakdown →